Stock Market Cafe
  • Home
  • Trading News
  • Email Whitelisting
  • Privacy Policy
  • Home
  • Trading News
  • Email Whitelisting
  • Privacy Policy
No Result
View All Result
Stock Market Cafe
No Result
View All Result
Home Trading News

J&J plans to split into two companies, separating consumer products and pharmaceutical businesses

by
November 12, 2021
in Trading News
0
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Health-care conglomerate Johnson & Johnson announced plans Friday to split its consumer products business from its pharmaceutical and medical device operations, creating two publicly traded companies. The news sent shares higher in premarket trading.

The separation will sheer off its household products unit, maker of Band-Aid bandages, Aveeno and Neutrogena skin care products and Listerine, from its riskier, but faster-growing division that makes and sells prescription drugs and medical devices, including its Covid-19 vaccine.

RELATED POSTS

Shell to build Europe’s ‘largest’ renewable hydrogen plant to help power Dutch refinery

Sterling, FTSE 100 gain ahead of UK PM Boris Johnson’s expected resignation

“Following a comprehensive review, the board and management team believe that the planned separation of the consumer health business is the best way to accelerate our efforts to serve patients, consumers, and healthcare professionals, create opportunities for our talented global team, drive profitable growth, and – most importantly – improve healthcare outcomes for people around the world,” outgoing CEO Alex Gorsky said in a statement.

The company said it hopes to complete the transaction in 18 to 24 months. The pharmaceutical and medical device division, which includes advanced technologies like robotics and AI, would retain the name Johnson & Johnson and have J&J’s incoming CEO Joaquin Duato at its helm.

Duato is taking over the role in January as previously planned. Those segments are expected to generate roughly $77 billion in revenue while the consumer products division is forecast to sell about $15 billion in products this year, the company said.

Its yet-to-be-named consumer products company will also inherit litigation stemming from lawsuits over claims that its Johnson’s Baby Powder causes cancer, allegations the company has vehemently denied.

Shares of J&J were up more than 3% in premarket trading after the announcement.

J&J was already undergoing a major transition with Gorsky’s departure as CEO. He will remain on as executive chairman of the new J&J, the company said.

Additionally, the company said it planned to keep its total dividend “at least at the same level” following the change. J&J currently sports a dividend yield of about 2.6%.

The announcement comes just days after General Electric said it plans to split into three separate companies, spinning out its medical unit from its aviation and energy units.

ShareTweetPin

Related Posts

Shell to build Europe’s ‘largest’ renewable hydrogen plant to help power Dutch refinery

by
July 7, 2022
0

In this article AI-FR ENR-DE BP BP.-GB SHEL-GB On Wednesday, Shell said the Holland Hydrogen I facility would be "Europe's...

Sterling, FTSE 100 gain ahead of UK PM Boris Johnson’s expected resignation

by
July 7, 2022
0

Sterling hit a day's high Thursday following multiple unconfirmed reports that Prime Minister Boris Johnson is set to resign. The...

UK government resignations top 50 as PM Boris Johnson teeters on the brink

by
July 7, 2022
0

British Prime Minister Boris Johnson attends a news conference during a NATO summit in Madrid, Spain June 30, 2022. Yves...

Samsung’s ‘better than feared’ earnings spur chip stock rally

by
July 7, 2022
0

In this article SSNNF 2330-TW 2303-TW .FKRX300 Samsung shares rose on Thursday, dragging Asian chipmakers higher after the South Korean...

American Airlines pilots get triple pay for trips dropped in scheduling glitch

by
July 7, 2022
0

An American Airlines Boeing 787-9 Dreamliner approaches for a landing at the Miami International Airport on December 10, 2021 in...

Next Post

Black Knight: Number of Mortgages in Forbearance Declines

J&J plans to split into two companies, separating consumer products and pharmaceutical businesses

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

email

Get the daily email about stock.

Please Enter Your Email Address:

By opting in you agree to our Privacy Policy. You also agree to receive emails from us and our affiliates. Remember that you can opt-out any time, we hate spam too!

MOST VIEWED

  • Crocs sees fourth-quarter sales up 42%, CEO Andrew Rees says 2021 was ‘exceptional year’

    0 shares
    Share 0 Tweet 0
  • Buying a car from the factory sounds expensive, but it can actually save you money. Here’s how to do it.

    0 shares
    Share 0 Tweet 0
  • Roth TSP vs. Roth IRA: How Do They Compare?

    0 shares
    Share 0 Tweet 0
  • The states that won’t tax military retirement in 2022

    0 shares
    Share 0 Tweet 0
  • Allbirds stock has plunged 50% in two months, now one top analyst says buy it

    0 shares
    Share 0 Tweet 0
  • Home
  • Trading News
  • Email Whitelisting
  • Privacy Policy
All rights reserved by www.stockmarket-cafe.com
No Result
View All Result
  • Home
  • Trading News
  • Email Whitelisting
  • Privacy Policy

All rights reserved by www.stockmarket-cafe.com